Remunity Pump for Remodulin (treprostinil) Injection
Infusion Pump, Drug Specific, Pharmacy-Filled. 510(k) K202690, from Deka Research and Development (Manchester, NH). Product code QJY, class 2.
As of Nov 19, 2026, K202690 is an FDA 510(k) held by Deka Research and Development, substantially equivalent on Dec 30, 2020 after 106 days, with no recalls tied to it in FDA's recall database.
- Review time: 106 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Remunity Subcutaneous Infusion System (the Remunity System) is intended for continuous subcutaneous delivery of Remodulin® (treprostinil) Injection for use in adults (greater than 22 years of age).
- Unity Subcutaneous Infusion System for RemodulinK191313 · DEKA Research & Development · Feb 21, 2020
- Remunity SystemK240256 · Deka Research and Development · Jun 12, 2024
- Remunity SystemK243354 · Deka Research & Development Corp. · Nov 27, 2024
- Remunity SystemK240256 · Deka Research and Development · Jun 12, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 15, 2020
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5725
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files